Skip to content
Food and Agriculture Tech Series B Founded 2014

Phylos Bioscience

Phylos Bioscience is an agricultural genomics and cannabis biotechnology company that develops elite F1 hybrid cannabis seeds and natural THC products, empowering growers of all sizes to produce high-quality cannabis cost-effectively. The company offers the industry's first elite, phenotypically-stable, fully-feminized true F1 hybrid seed lines, featuring high-THC content, unique aromas, and agronomic traits that…

📍 Portland, United States · Forestry Tech,

Funding snapshot

Last roundSeries B
Amount$3M
Date31 December 2025
Total raised$31M
Team size50

About

Phylos Bioscience is an agricultural genomics and cannabis biotechnology company that develops elite F1 hybrid cannabis seeds and natural THC products, empowering growers of all sizes to produce high-quality cannabis cost-effectively. The company offers the industry's first elite, phenotypically-stable, fully-feminized true F1 hybrid seed lines, featuring high-THC content, unique aromas, and agronomic traits that make growing easier and cheaper while outperforming clonal cultivars. Phylos' seed-grown plants rival the uniformity of clonal varieties for harvest height, wet biomass, and total THC, as demonstrated in the company's uniformity studies, addressing a critical factor that has long hindered the adoption of seed-based production in cannabis. The company's F1 hybrid seeds also mitigate Hop Latent Viroid (HLVd) risk, a significant pathogen threat in cannabis cultivation, by starting with clean, production-ready seed stock rather than infected clonal material. Phylos leverages its deep genomics expertise to apply advanced breeding techniques and genomic selection to cannabis, bringing modern agricultural science to a crop that has historically lacked rigorous breeding programs. The company provides educational resources including webinars on breeding for better solventless extraction and insights on how genomics is shaping the future of cannabis breeding. Founded in 2014 and headquartered in Portland, Oregon, Phylos Bioscience has raised $31.2M in Series B funding from investors including Organigram, Merida Capital Partners, Accomplice, Entourage Effect Capital, Arcadian Capital, Artemis Growth Partners, and V. Gastevich Investments.

Business model

Cannabis HealthTech > Cannabis Farming > Enablers > Farm Inputs > Seeds > GMO,

Genomics > Applied Genomics > Agrigenomics,

Life Sciences Platforms and Tools > Research Services > Analytical Testing > Cannabis Testing,

Crop Tech > Farm Inputs > Seeds > Horticulture > GMO > Cannabis,

Forestry Tech > Seeds Planting > Genetic Seedlings

Team background

College Wise > Columbia University

Institutional investors

Organigram Merida Capital Partners Accomplice Entourage Effect Capital Arcadian Capital Artemis Growth Partners V. Gastevich Investments

Latest coverage

No articles yet.

Raising like Phylos Bioscience?

Analyze your pitch deck before your next raise.

Analyze My Deck →